In tauopathies, such as Alzheimer's disease, tau is distributed more in the somatodendritic compartment, where it aggregates into filamentous structures, the formation of which correlates with cognitive impairments in patients. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.